WT
DGX icon

Wilmington Trust’s Quest Diagnostics DGX Stock Holding History

Wilmington Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$298K Hold
5,071
– – 0.01% 619
2014
Q1 		$294K Buy
5,071
+130
+3% +$6.97K 0.01% 597
2013
Q4 		$264K Hold
4,941
– – ﹤0.01% 617
2013
Q3 		$305K Sell
4,941
-45
-0.9% -$2.69K 0.01% 564
2013
Q2 		$302K Buy
+4,986
New +$297K 0.01% 553

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wilmington Trust's DGX Position: Q2 2014 in Review

Wilmington Trust held its Quest Diagnostics (DGX) position steady in Q2 2014 at 5,071 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #619.

Wilmington Trust first reported a position in DGX in Q2 2013 and has held it in 5 quarters since. The position peaked at $305K in Q3 2013. 496 funds tracked by Wall St. Rank hold DGX as of Q2 2014.

  • Wilmington Trust held 5,071 shares of Quest Diagnostics worth $298K as of Q2 2014.
  • Wilmington Trust left its Quest Diagnostics share count unchanged in Q2 2014.
  • Quest Diagnostics made up 0.01% of Wilmington Trust's portfolio in Q2 2014, its #619 holding.
  • Wilmington Trust first reported a position in Quest Diagnostics in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Trust's Quest Diagnostics position peaked at $305K in Q3 2013.
  • 496 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.